The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Nanotechnology applied to the treatment of malaria
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Various carrier system(s)- mediated genetic vaccination strategies against malaria - Retracted
Tyagi, R. K., Sharma, P., Vyas, S. P., & Mehta, A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.4.499 · Cited by 13
RetractedRecent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Nanocapsule formation by interfacial polymer deposition following solvent displacement
Fessi, H., Puisieux, F., Devissaguet, J. P., Ammoury, N., & Benita, S. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90281-0 · Cited by 2,288
Cyclodextrins as pharmaceutical solubilizers
Brewster, M. E., & Loftsson, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.012 · Cited by 1,882
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
TORCHILIN, V (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.009 · Cited by 1,273
Endocytic mechanisms for targeted drug delivery☆
BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Novel applications of liposomes
Lasic, D. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(98)01220-7 · Cited by 867
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
Gref, R., Domb, A., Quellec, P., Blunk, T., Müller, R. H., Verbavatz, J. M., & Langer, R. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00026-4 · Cited by 820
Handbook of Pharmaceutical Controlled Release Technology
Wise, D. L. (2000) · CRC Press eBooks · doi:10.1201/9781482289985 · Cited by 768
Malaria: progress, perils, and prospects for eradication
Greenwood, B. M., Fidock, D. A., Kyle, D. E., Kappe, S. H. I., Alonso, P. L., Collins, F. H., & Duffy, P. E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33996 · Cited by 709
Liposomes as immunological adjuvants
ALLISON, A. C., & GREGORIADIS, G. (1974) · Nature · doi:10.1038/252252a0 · Cited by 675
Nanotechnology in vaccine delivery
Peek, L. J., Middaugh, C. R., & Berkland, C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.017 · Cited by 562
Nanocapsule Technology: A Review
Couvreur, P., Barratt, G., Fattal, E., & Vauthier, C. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.10 · Cited by 555
Kester, K. E., Cummings, J. F., Ofori‐Anyinam, O., Ockenhouse, C. F., Krzych, U., Moris, P., Schwenk, R., Nielsen, R. A., Debebe, Z., Pinelis, E., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600120 · Cited by 524
Whitworth, J., Morgan, D., Quigley, M., Smith, A., Mayanja, B., Eotu, H., Omoding, N., Okongo, M., Malamba, S., & Ojwiya, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02727-6 · Cited by 472
Artemisinins: their growing importance in medicine
Krishna, S., Bustamante, L., Haynes, R. K., & Staines, H. M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.07.004 · Cited by 388
Primaquine revisited six decades after its discovery
Vale, N., Moreira, R., & Gomes, P. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.08.011 · Cited by 367
Newton, C. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00008-4 · Cited by 348
Wong, H. L., Bendayan, R., Rauth, A. M., Xue, H. Y., Babakhanian, K., & Wu, X. Y. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101154 · Cited by 344
Colloidal drug carriers: achievements and perspectives
Barratt, G. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180300002 · Cited by 333
Enzyme entrapment in liposomes
Gregoriadis, G., Leathwood, P. D., & Ryman, B. E. (1971) · FEBS Letters · doi:10.1016/0014-5793(71)80109-6 · Cited by 331
Mosqueira, V. C. F., Legrand, P., Gulik, A., Bourdon, O., Gref, R., Labarre, D., & Barratt, G. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00043-6 · Cited by 325
Self-citationArteether, a new antimalarial drug: synthesis and antimalarial properties
Brossi, A., Venugopalan, B., Dominguez Gerpe, L., Yeh, H. J. C., Flippen-Anderson, J. L., Buchs, P., Luo, X. D., Milhous, W., & Peters, W. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00398a026 · Cited by 320
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles☆
DATE, A., JOSHI, M., & PATRAVALE, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.009 · Cited by 293
Mosqueira, V. C. F., Legrand, P., Morgat, J.-L., Vert, M., Mysiakine, E., Gref, R., Devissaguet, J.-P., & Barratt, G. (2001) · Pharmaceutical Research · doi:10.1023/a:1012248721523 · Cited by 289
Self-citationTherapeutic applications of colloidal drug carriers
Barratt, G. M. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00255-8 · Cited by 282
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting
Bhadra, D., Yadav, A. K., Bhadra, S., & Jain, N. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.026 · Cited by 280
Targeted drug conjugates: principles and progress
Garnett, M. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00227-7 · Cited by 262
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey
Madden, T. D., Harrigan, P. R., Tai, L. C. L., Bally, M. B., Mayer, L. D., Redelmeier, T. E., Loughrey, H. C., Tilcock, C. P. S., Reinish, L. W., & Cullis, P. R. (1990) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(90)90131-a · Cited by 255
Wong, J., Brugger, A., Khare, A., Chaubal, M., Papadopoulos, P., Rabinow, B., Kipp, J., & Ning, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.008 · Cited by 251
Role of Nanotechnology in Pharmaceutical Product Development
Devalapally, H., Chakilam, A., & Amiji, M. M. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20875 · Cited by 230
L�ck, M., Paulke, B.-R., Schr�der, W., Blunk, T., & M�ller, R. H. (1998) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19980305)39:3<478::aid-jbm19>3.0.co;2-6 · Cited by 225
Direct access to serum macromolecules by intraerythrocytic malaria parasites
Pouvelle, B., Spiegel, R., Hsiao, L., Howard, R. J., Morris, R. L., Thomas, A. P., & Taraschi, T. F. (1991) · Nature · doi:10.1038/353073a0 · Cited by 218
Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine
Singh, K. K., & Vingkar, S. K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.035 · Cited by 215
Cullis, P. R., Hope, M. J., Bally, M. B., Madden, T. D., Mayer, L. D., & Fenske, D. B. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(97)00006-3 · Cited by 212
Transporters involved in resistance to antimalarial drugs
Valderramos, S. G., & Fidock, D. A. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.09.005 · Cited by 200
Duarte, J., Deshpande, P., Guiyedi, V., Mécheri, S., Fesel, C., Cazenave, P.-A., Mishra, G. C., Kombila, M., & Pied, S. (2007) · Malaria Journal · doi:10.1186/1475-2875-6-1 · Cited by 194
Gupta, Y., Jain, A., & Jain, S. K. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.7.0004 · Cited by 192
Diagnosis and management of the neurological complications of falciparum malaria
Mishra, S. K., & Newton, C. R. J. C. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.23 · Cited by 177
Joshi, M., Pathak, S., Sharma, S., & Patravale, V. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.032 · Cited by 168
Modification of nanostructured materials for biomedical applications
Xu, T., Zhang, N., Nichols, H. L., Shi, D., & Wen, X. (2006) · Materials Science and Engineering C · doi:10.1016/j.msec.2006.05.029 · Cited by 155
Krettli, A. U., de Andrade‐Neto, V. F., Brandão, M. G. L., & Ferrari, W. M. (2001) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762001000800002 · Cited by 139
Tuftsin-bearing liposomes in treatment of macrophage-based infections
Agrawal, A. K., & Gupta, C. M. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00061-7 · Cited by 135
Design and selection of vaccine adjuvants: animal models and human trials
Alving, C. R. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00174-3 · Cited by 125
Prodrugs of bisthiazolium salts are orally potent antimalarials
Vial, H. J., Wein, S., Farenc, C., Kocken, C. H. M., Nicolas, O., Ancelin, M., Bressolle, F., Thomas, A. W., & Calas, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404037101 · Cited by 117
Wong, J. W., & Yuen, K. H. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00796-7 · Cited by 112
Mosqueira, V. C. F., Loiseau, P. M., Bories, C., Legrand, P., Devissaguet, J., & BARRATT, G. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1222-1228.2004 · Cited by 109
Self-citationKester, K. E., McKinney, D., Tornieporth, N., Ockenhouse, C. F., Heppner, D. G., Hall, T., Wellde, B. T., White, K., Sun, P., Schwenk, R., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.005 · Cited by 107
Owais, M., Varshney, G. C., Choudhury, A., Chandra, S., & Gupta, C. M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.180 · Cited by 104
PEGylated Peptide Dendrimeric Carriers for the Delivery of Antimalarial Drug Chloroquine Phosphate
Bhadra, D., Bhadra, S., & Jain, N. K. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-9396-9 · Cited by 102
Development of SMEDDS using natural lipophile: Application to β-Artemether delivery
Mandawgade, S. D., Sharma, S., Pathak, S., & Patravale, V. B. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.021 · Cited by 100
Recent highlights in antimalarial drug resistance and chemotherapy research
Fidock, D. A., Eastman, R. T., Ward, S. A., & Meshnick, S. R. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2008.09.005 · Cited by 98
Particle-based vaccines for transcutaneous vaccination
Combadière, B., & Mahé, B. (2007) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2007.07.015 · Cited by 95
Biagini, G. A., Pasini, E. M., Hughes, R., de Koning, H. P., Vial, H. J., O’Neill, P. M., Ward, S. A., & Bray, P. G. (2004) · Blood · doi:10.1182/blood-2004-03-1084 · Cited by 94
Richards, R. L., Rao, M., Wassef, N. M., Glenn, G. M., Rothwell, S. W., & Alving, C. R. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2859-2865.1998 · Cited by 91
Grimwade, K., French, N., MBATHA, D. D., ZUNGU, D. D., Dedicoat, M. J., & Gilks, C. F. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000101188.95433.60 · Cited by 90
Tafenoquine: a promising new antimalarial agent
Crockett, M. E., & Kain, K. C. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.5.705 · Cited by 87
Qiu, L., Jing, N., & Jin, Y. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.010 · Cited by 87
Characterization of macromolecular transport pathways in malaria-infected erythrocytes
Goodyer, I. D., Pouvelle, B., Schneider, T. G., Trelka, D. P., & Taraschi, T. F. (1997) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(97)00039-x · Cited by 87
Apicoplast fatty acid biosynthesis as a target for medical intervention in apicomplexan parasites.
Gornicki, P. (2003) · International Journal of Parasitology · doi:10.1016/s0020-7519(03)00133-4 · Cited by 83
Henriksen, I., Våagen, S. R., Sande, S. A., et al. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04801-6 · Cited by 82
Mettens, P., Dubois, P. M., Demoitié, M., Bayat, B., Donner, M.-N., Bourguignon, P., Stewart, V. A., Heppner, D. G., Garçon, N., & Cohen, J. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.018 · Cited by 81
Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices
Leite, E. A., Grabe‐Guimarães, A., Guimarães, H. N., Machado-Coelho, G. L. L., BARRATT, G. M., & Mosqueira, V. C. F. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.12.019 · Cited by 81
Self-citationLongmuir, K. J., Robertson, R. T., Haynes, S. M., Baratta, J. L., & Waring, A. J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9609-x · Cited by 80
Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo
Haas, S. E., Bettoni, C. C., de Oliveira, L. K., Guterres, S. S., & Costa, T. D. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.02.024 · Cited by 78
Antimalarial drugs: current status and new developments
Rathore, D., McCutchan, T. F., Sullivan, M., & Kumar, S. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.7.871 · Cited by 78
Chimanuka, B., Gabriëls, M., Detaevernier, M. R., & Plaizier-vercammen, J. A. (2002) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(01)00611-2 · Cited by 77
Stensrud, G., Sande, S. A., Kristensen, S., & Smistad, G. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00338-0 · Cited by 74
Physical and chemical evaluation of liposomes, containing artesunate
Gabriëls, M., & Plaizier-vercammen, J. A. (2003) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(02)00678-7 · Cited by 72
PEGylated peptide-based dendritic nanoparticulate systems for delivery of artemether
Bhadra, D., Bhadra, S., & Jain, N. K. (2005) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(05)50008-x · Cited by 71
Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria
Joshi, M., Pathak, S., Sharma, S., & Patravale, V. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.012 · Cited by 71
World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
Price, R. N., Dorsey, G., Ashley, E. A., Barnes, K. I., Baird, J. K., D’Alessandro, U., Guerin, P. J., Laufer, M. K., Naidoo, I., Nosten, F. H., et al. (2007) · Malaria Journal · doi:10.1186/1475-2875-6-119 · Cited by 69
World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
Bacon, D., Jambou, R., Fandeur, T., Bras, J. L., Wongsrichanalai, C., Fukuda, M. M., Ringwald, P., Sibley, C. H., & Kyle, D. E. (2007) · Malaria Journal · doi:10.1186/1475-2875-6-120 · Cited by 67
Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles
Föger, F., Noonpakdee, W., Loretz, B., Joojuntr, S., Salvenmoser, W., Thaler, M., & Bernkop‐Schnürch, A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.034 · Cited by 66
Primaquine-loaded poly(lactide) nanoparticles: physicochemical study and acute tolerance in mice
Júnior, J. M. R., Fessi, H., Bories, C., Puisieux, F., & Devissaguet, J. P. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04135-4 · Cited by 66
Sharma, M. K., Rao, V. K., Agarwal, G. S., Rai, G. P., Gopalan, N., Prakash, S., Sharma, S. K., & Vijayaraghavan, R. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01022-08 · Cited by 61
Primaquine liposomes in the chemotherapy of experimental murine malaria
Pirson, P., Steiger, R. F., Trouet, A., Gillet, J., & Herman, F. (1980) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1980.11687359 · Cited by 60
Charpian, S., & Przyborski, J. M. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00648.x · Cited by 58
Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy
Dierling, A. M., & Cui, Z. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.07.015 · Cited by 57
Functional drug targeting to erythrocytes in vivo using antibody bearing liposomes as drug vehicles
Agrawal, A., Singhal, A. K., & Gupta, C. M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91118-1 · Cited by 56
Smith, L., Jones, C. O. H., Meek, S. R., & Webster, J. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.80.326 · Cited by 55
Antibody‐mediated targeting of liposomes to red cells in vivo
Singhal, A. K., & Gupta, C. M. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80632-9 · Cited by 47
Adjuvant therapy in cerebral malaria.
Mohanty, S., Patel, D. K., Pati, S. S., & Mishra, S. K. (2006) · PubMed · Cited by 47
Development of new derivatives of primaquine by association with lysosomotropic carriers.
Trouet, A., Pirson, P., Steiger, R. F., Masquelier, M., Baurain, R., & Gillet, J. (1981) · Europe PMC (PubMed Central) · Cited by 43
Clinical developments in drug delivery nanotechnology
Forrest, M. L., & Kwon, G. S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.02.013 · Cited by 42
Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66
Carcaboso, A. M., Hernández, R. M., Igartúa, M., Rodríguez‐Gascón, A., Rosas, J. E., Patarroyo, M. E., & Pedraz, J. L. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00266-7 · Cited by 41
Winstanley, P., & Ward, S. A. (2006) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(05)61002-0 · Cited by 40
Antimalarial drug use in general populations of tropical Africa
Gardella, F., Assi, S.-B., Simon, F., Bogreau, H., Eggelte, T. A., Ba, F., Foumane, V. N., Henry, M.-C., Kientega, P. T., Basco, L. K., et al. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-124 · Cited by 39
In vivo evaluation of arteether liposomes
Bayomi, M. A., Al-Angary, A. A., Al‐Meshal, M. A., et al. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00182-3 · Cited by 38
Drug Entrapment in Liposomes: Possibilities for Chemotherapy
Gregoriadis, G. C. (1974) · Biochemical Society Transactions · doi:10.1042/bst0020117 · Cited by 35
Delivery strategies for antiparasitics
Kayser, O., & Kiderlen, A. F. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.2.197 · Cited by 32
Of malaria, metabolism and membrane transport
Becker, K., & Kirk, K. (2004) · Trends in Parasitology · doi:10.1016/j.pt.2004.09.004 · Cited by 29
Richier, E., Biagini, G. A., Wein, S., Boudou, F., Bray, P. G., Ward, S. A., Précigout, É., Calas, M., Dubremetz, J., & Vial, H. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00443-06 · Cited by 28
Malaria: A sporozoite runs through it
Krettli, A. U., & Miller, L. H. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00221-4 · Cited by 27
Robertson, R. T., Baratta, J. L., Haynes, S. M., & Longmuir, K. J. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21211 · Cited by 26
Characterization,in vitroandin vivostudies on primaquine diphosphate liposomes
Arica, B., Özer, A. Y., Ercan, M. T., & Hıncal, A. A. (1995) · Journal of Microencapsulation · doi:10.3109/02652049509006778 · Cited by 26
Laham, A., Claperon, N., Durussel, J. J., Fattal, E., Delattre, J., Puisieux, F., Couvreur, P., & Rossignol, P. (1988) · Pharmacological Research Communications · doi:10.1016/s0031-6989(88)80117-6 · Cited by 25
Pouvelle, B., Matarazzo, V. A., Jurzynski, C., Nemeth, J., Ramharter, M., Rougon, G., & Gysin, J. (2007) · Infection and Immunity · doi:10.1128/iai.01852-06 · Cited by 22
Plasmodium vinckei:Optimization of Desferrioxamine B Delivery in the Treatment of Murine Malaria
Postma, N. S., Hermsen, C. C., Zuidema, J., & Eling, W. M. C. (1998) · Experimental Parasitology · doi:10.1006/expr.1998.4282 · Cited by 20
Haynes, S. M., Longmuir, K. J., Robertson, R. T., et al. (2008) · Drug Delivery · doi:10.1080/10717540802006211 · Cited by 20
Peeters, P. A. M., de Leest, K., Eling, W. M. C., et al. (1989) · Pharmaceutical Research · doi:10.1023/a:1015927614920 · Cited by 17
Newton, P. N., Ward, S. A., Angus, B., Chierakul, W., Dondorp, A. M., Ruangveerayuth, R., Silamut, K., Teerapong, P., Suputtamongkol, Y., Looareesuwan, S., et al. (2005) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.01.008 · Cited by 16
A Malaria Vaccine for Control: More Progress
Breman, J. G., & Plowe, C. V. (2009) · The Journal of Infectious Diseases · doi:10.1086/600121 · Cited by 11
Alternative tools for field analysis on malarial infection: a reappraisal.
Wiwanitkit, V. (2009) · PubMed · Cited by 5
Cited by
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,864
Cheng, Y., Zhao, L., Li, Y., & Xu, T. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00097c · Cited by 515
The role of nanotechnology in the treatment of viral infections
Singh, L., Kruger, H. G., Maguire, G. E. M., Govender, T., & Parboosing, R. (2017) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936117713593 · Cited by 360
Lipid-based nanoparticle technologies for liver targeting
Böttger, R., Pauli, G., Chao, P.-H., AL Fayez, N., Hohenwarter, L., & Li, S.-D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.017 · Cited by 264
Urbán, P., Estelrich, J., Cortés, A., & Fernàndez-Busquets, X. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.001 · Cited by 90
Metadata
- Authors
- Santos-Magalhães, N. S., & Mosqueira, V. C. F.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 62
- Issue
- 4-5
- Pages
- 560-575
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1987250403
- Cited by
- 286
- References
- 108
- FWCI
- 0.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.